BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10706572)

  • 1. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
    Armstrong GL; Alter MJ; McQuillan GM; Margolis HS
    Hepatology; 2000 Mar; 31(3):777-82. PubMed ID: 10706572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of hepatitis C in the United States.
    Kim WR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S30-4. PubMed ID: 12407574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis C.
    Alter MJ
    Hepatology; 1997 Sep; 26(3 Suppl 1):62S-65S. PubMed ID: 9305666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding hepatitis C.
    McHutchison JG
    Am J Manag Care; 2004 Mar; 10(2 Suppl):S21-9. PubMed ID: 15084064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of disease (GBD) for hepatitis C.
    Global Burden Of Hepatitis C Working Group
    J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
    Deuffic-Burban S; Poynard T; Sulkowski MS; Wong JB
    J Viral Hepat; 2007 Feb; 14(2):107-15. PubMed ID: 17244250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of hepatitis C virus infection. An update for clinicians.
    Pellicano R; Mladenova I; Dimitrova SM; Bruno CM; Sciacca C; Rizzetto M
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):1-7. PubMed ID: 15719001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission.
    Di Stefano R; Stroffolini T; Ferraro D; Usticano A; Valenza LM; Montalbano L; Pomara G; Craxì A
    J Med Virol; 2002 Jul; 67(3):339-44. PubMed ID: 12116024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB
    Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
    Schuval S; Van Dyke RB; Lindsey JC; Palumbo P; Mofenson LM; Oleske JM; Cervia J; Kovacs A; Dankner WN; Smith E; Nowak B; Ciupak G; Webb N; Eagle M; Smith D; Hennessey R; Goodman-Kerkau M; Levin MJ;
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):1007-13. PubMed ID: 15466691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy.
    Mariano A; Scalia Tomba G; Tosti ME; Spada E; Mele A
    Scand J Infect Dis; 2009; 41(9):689-99. PubMed ID: 19579149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C in Poland in 2006].
    Bobel D; Rosińska M
    Przegl Epidemiol; 2008; 62(2):325-32. PubMed ID: 18807475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of the epidemiology of hepatitis C in a North American population.
    Uhanova J; Tate RB; Tataryn DJ; Minuk GY
    J Hepatol; 2012 Oct; 57(4):736-42. PubMed ID: 22668641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.